Daniel J. Minion is a patent litigator who focuses on Hatch-Waxman litigation, chemicals litigation, and contested proceedings before the U.S. Patent and Trademark Office. In addition to first-chair litigation before District Courts, he has argued on behalf of major pharmaceutical companies at the U.S. Court of Appeals for the Federal Circuit and the Patent Trial and Appeal Board (for both petitioner and patent owner).
Dan has counseled on a wide range of pharmaceuticals in a variety of formulations used to treat breast and prostate cancer, renal disease, hypertension, arrhythmias, chronic pain, epilepsy, hormonal and genetic disorders, osteoporosis, Alzheimer’s, and multiple sclerosis.
Before joining Venable, Dan spent his entire career in private practice at Fitzpatrick, Cella, Harper & Scinto. Prior to law school, Dan worked as a medicinal chemist at Agouron Pharmaceuticals and obtained a master’s degree in organic chemistry for his synthetic studies on the viridin family of kinase inhibitors.
- Represented Sanofi Genzyme against several generics on patents relating to Cerdelga® for the treatment of Gaucher disease (D. Del.)
- Represented Grünenthal against Antecip in contested proceedings in the USPTO relating to the use of bisphosphonates for the treatment of chronic pain (PTAB)
- Represented Sanofi against several generics on patents relating to Multaq® for the treatment of atrial fibrillation (D. Del., Fed. Cir.)
- Represented Bone Care and Genzyme against several generics on patents relating to Hectorol® for the treatment of kidney disease (ND Ill., D. Del.)
- J.D. Benjamin N. Cardozo School of Law 2006
- M.S. University of Pittsburgh 2004
- B.S. Stanford University 1996
Bar Admissions : New York, United States Patent and Trademark Office
Court Admissions :
- U.S. District Court for the Southern District of New York
- U.S. District Court for the Eastern District of New York
- U.S. Court of Appeals for the Federal Circuit
Rate : $$$$